Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700793 | European Journal of Surgical Oncology (EJSO) | 2017 | 34 Pages |
Abstract
After neoadjuvant therapy for gastroesophageal adenocarcinoma, survival is determined by the same factors as after surgery alone. However, ypT stage is not an independent predictor. These results can facilitate the decision about postoperative continuation of chemotherapy in pretreated patients.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
U. Ronellenfitsch, M. Schwarzbach, R. Hofheinz, P. Kienle, K. Nowak, M. Kieser, T.E. Slanger, B. Burmeister, D. Kelsen, D. Niedzwiecki, C. Schuhmacher, S. Urba, C. van de Velde, T.N. Walsh, M. Ychou, K. Jensen,